Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Topical hemostatic agents for malignancy-related GI bleeding: Is it time to prioritize their use?

Gastrointestinal endoscopy·2022

Same author

ERCP in the evaluation of biliary strictures: Tissue is the issue! Is FISH the answer?

Gastrointestinal endoscopy·2022

Same author

Red dichromatic imaging in acute GI bleeding: Does it make a difference?

Gastrointestinal endoscopy·2022

Same author

Factors associated with complete clip closure after endoscopic mucosal resection of large colorectal polyps.

Endoscopy·2020

Same author

Effects of Blended (Yellow) vs Forced Coagulation (Blue) Currents on Adverse Events, Complete Resection, or Polyp Recurrence After Polypectomy in a Large Randomized Trial.

Gastroenterology·2020

Same author

Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial.

Gastroenterology·2019

Search research articles

Related Experiment Video

Updated: May 18, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Cholangiocarcinoma treatment.

Halim Charbel¹, Firas H Al-Kawas

¹Division of Gastroenterology, Georgetown University Hospital, 2nd floor, Main Hospital, M2025, 3800 Reservoir road NW, Washington, DC 20007, USA. halimcharbel@hotmail.com

Current Gastroenterology Reports

|September 13, 2012

Summary

Cholangiocarcinoma (bile duct cancer) is difficult to treat due to late diagnosis and limited options. Liver transplant and surgical resection offer cures, while other therapies focus on palliation and emerging treatments.

Area of Science:

Oncology
Gastroenterology
Surgical Oncology

Background:

Cholangiocarcinoma (CCA) is a bile duct cancer with poor prognosis.
Diagnosis is often late, complicating treatment.
Effective treatments are limited, especially when complete resection is not feasible.

Purpose of the Study:

To review the current treatment landscape for cholangiocarcinoma.
To highlight challenges in CCA management.
To discuss palliative and emerging therapeutic strategies.

Main Methods:

Literature review of cholangiocarcinoma treatment modalities.
Analysis of surgical, transplant, and palliative interventions.
Evaluation of adjuvant, neoadjuvant, and novel therapies.

Related Experiment Videos

Last Updated: May 18, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Main Results:

Complete surgical resection and liver transplant are potentially curative but applicable to few patients.
Biliary stenting provides palliation for biliary obstruction.
Photodynamic therapy, radiation, and chemotherapy offer palliative and adjuvant roles.

Conclusions:

Management of CCA is challenging, often requiring palliative care.
Emerging ablative techniques and targeted chemotherapies show promise for improved outcomes.
Multidisciplinary approaches are crucial for optimizing patient care.